Barry Flannelly

Barry Flannelly

Directeur/Membre du Conseil chez PROTARA THERAPEUTICS, INC.

Fortune : 4 M $ au 31/10/2026

68 ans
Health Technology
Consumer Services
Health Services

Profil

Barry P Flannelly is an Independent Director at Protara Therapeutics, Inc. since 2020.
Former roles include Executive VP & General Manager-North America at Incyte Corp.
from 2015 to 2025, Chief Executive Officer at OSS Healthcare, Inc. from 2013 to 2014, Director at Genomic Health, Inc. in 2019, VP-Global Product Strategy & Commercial Planning at Nektar Therapeutics from 2011 to 2013, Senior Vice President-Commercial at Onyx Pharmaceuticals, Inc. from 2008 to 2011, and Manager-Pharmacy Services at Johns Hopkins Oncology Center.
Education includes undergraduate studies at Massachusetts College of Pharmacy & Health Science, an MBA from the University of Baltimore, and a doctorate from the University of Maryland School of Pharmacy.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/07/2025 35 149 ( 0,02% ) 4 M $ 31/10/2026
15/06/2026 0 ( -.--% ) - $ 31/10/2026

Postes actifs de Barry Flannelly

SociétésPosteDébut
PROTARA THERAPEUTICS, INC. Directeur/Membre du Conseil 23/07/2020

Anciens postes connus de Barry Flannelly

SociétésPosteFin
INCYTE CORPORATION Corporate Officer/Principal 31/07/2025
GENOMIC HEALTH, INC. Directeur/Membre du Conseil 08/11/2019
OSS Healthcare, Inc.
Directeur Général 01/07/2014
NEKTAR THERAPEUTICS Corporate Officer/Principal 01/04/2013
Corporate Officer/Principal 01/01/2011
Voir l'expérience en détail de Barry Flannelly

Formation de Barry Flannelly

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

OSS Healthcare, Inc.

Consumer Services

Health Technology

Johns Hopkins Oncology Center

  1. Bourse
  2. Insiders
  3. Barry Flannelly